I don't understand. VXRT media release of 22JAN20 reported...

I don't understand. VXRT media release of 22JAN20 reported success of phase 2 influenza A challenge study in a randomized double-blind study using Vaxart oral tablet vaccine with FLUZONE (the current most efficacious flu vacine) as the comparator and a placebo control. That seems to be the gold standard for testing at this stage of development?

I know there is a long way to go before we have an approved vaccine (if ever), but it should have at least boosted the price of VXRT.

Or am I missing something fundamental - perhaps wishful thinking on my part makes me read things that are not there ( I am underwater in excess of $100K from the Biota fiasco, so I regularly indulgence myself in the what ifs).